105 related articles for article (PubMed ID: 12493423)
1. Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients.
Malyszko J; Hryszko T; Malyszko JS; Wolczyński S; Myśliwiec M
Transplant Proc; 2002 Dec; 34(8):3211-4. PubMed ID: 12493423
[No Abstract] [Full Text] [Related]
2. [Parvovirus B19 infection: diagnosing and treating a kidney transplant patient].
León LR; Curcio D; Casadei D
Nefrologia; 2010; 30(6):704. PubMed ID: 21113225
[No Abstract] [Full Text] [Related]
3. Pure red cell aplasia due to parvovirus B19 infection in a renal transplant patient: a case report.
So BJ; Chae KM; Lee KK; Lee YJ; Jeong BH
Transplant Proc; 2000 Nov; 32(7):1954-6. PubMed ID: 11120017
[No Abstract] [Full Text] [Related]
4. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients?
Lee PC; Hung CJ; Lin YJ; Wang JR; Jan MS; Lei HY
Transplantation; 2002 May; 73(10):1635-9. PubMed ID: 12042652
[TBL] [Abstract][Full Text] [Related]
5. B19 virus infection in renal transplant recipients.
Cavallo R; Merlino C; Re D; Bollero C; Bergallo M; Lembo D; Musso T; Leonardi G; Segoloni GP; Ponzi AN
J Clin Virol; 2003 Apr; 26(3):361-8. PubMed ID: 12637086
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.
Gallinella G; Manaresi E; Venturoli S; Grazi GL; Musiani M; Zerbini M
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):811-3. PubMed ID: 10614957
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients.
Sharif A; Aghakhani A; Velayati AA; Banifazl M; Sharif MR; Razeghi E; Kheirkhah D; Kazemimanesh M; Bavand A; Ramezani A
Intervirology; 2016; 59(3):179-185. PubMed ID: 28142135
[TBL] [Abstract][Full Text] [Related]
8. Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients.
Becker MR; Schneider B; Reber U; Pöge U; Klein B; Klehr HU; Zhou H; Fischer HP; Eis-Hübinger AM
Transplant Proc; 2005 Dec; 37(10):4306-8. PubMed ID: 16387104
[TBL] [Abstract][Full Text] [Related]
9. Antenatal parvovirus infection: clinical implications.
Tchernia G
Pediatr Hematol Oncol; 1998; 15(1):7-10. PubMed ID: 9509501
[No Abstract] [Full Text] [Related]
10. [Antibodies against human parvovirus B19 in the Madrid community].
de Ory F; Pachón I; Ramírez R; Echevarría JM
Enferm Infecc Microbiol Clin; 1999; 17(7):364-5. PubMed ID: 10535193
[No Abstract] [Full Text] [Related]
11. Anemia as a complication of parvovirus b19 infection in renal transplant recipients.
Čapenko S; Kozireva S; Folkmane I; Bernarde K; Rozentāls R; Murovska M
Medicina (Kaunas); 2012; 48(6):299-304. PubMed ID: 22885363
[TBL] [Abstract][Full Text] [Related]
12. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients - a prospective study.
Park JB; Kim DJ; Woo SY; Choi GS; Chun JM; Jung GO; Kwon CH; Kim SJ; Joh JW; Lee SK
Transpl Int; 2009 Apr; 22(4):455-62. PubMed ID: 19144091
[TBL] [Abstract][Full Text] [Related]
14. [Parvovirus B19 infection and its clinical picture].
Dudina KR; Znoĭko OO; Iushchuk ND
Ter Arkh; 2007; 79(11):75-8. PubMed ID: 18219981
[No Abstract] [Full Text] [Related]
15. Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients.
Shimmura H; Tanabe K; Ishikawa N; Tokumoto T; Toda F; Toma H
Transplant Proc; 2000 Nov; 32(7):1967-70. PubMed ID: 11120023
[No Abstract] [Full Text] [Related]
16. Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients.
Bertoni E; Rosati A; Zanazzi M; Azzi A; Zakrewska K; Guidi S; Salvadori M
Transplant Proc; 1997; 29(1-2):818-9. PubMed ID: 9123540
[No Abstract] [Full Text] [Related]
17. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
[TBL] [Abstract][Full Text] [Related]
18. [Observations on human parvovirus B19 infection diagnosed in 2011].
Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
20. Recurrent anemia in kidney transplant recipients with parvovirus B19 infection.
Renoult E; Bachelet C; Krier-Coudert MJ; Diarrassouba A; André JL; Kessler M
Transplant Proc; 2006 Sep; 38(7):2321-3. PubMed ID: 16980079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
